Cholecystokinin Octapeptide Antagonized Opioid Analgesia Mediated by Μ- and Κ- but Not Δ-Receptors in the Spinal Cord of the Rat

XJ WANG,XH WANG,JS HAN
DOI: https://doi.org/10.1016/0006-8993(90)91629-u
IF: 3.61
1990-01-01
Brain Research
Abstract:Intrathecal (ith) injection of cholecystokinin octapeptide (CCK-8) to the rat with single dose of 4 or 40 ng, or successive doses from 0.1 to 1 μg at 10 min intervals produced neither analgesia nor hyperalgesia. However, the analgesia produced by ith injection of PL017, a specific μ-receptor agonist or 66A-078, a specific κ-receptor agonist could be markedly antagonized by CCK-8 at a dose as small as 4 ng. In contrast, analgesia produced by ith injection of δ-agonist DPDPE could not be blocked by CCK-8 even at a dose as high as 40 ng. Since the effect of CCK-8 could be totally reversed by the CCK receptor antagonist proglumide, this effect is most probably mediated by CCK receptors.
What problem does this paper attempt to address?